TARGETED THERAPY OF MYCOBACTERIUM AVIUM INFECTIONS
TARGETED THERAPY OF MYCOBACTERIUM AVIUM INFECTIONS
批准号:
3148868
负责人:
PATTISAPU R GANGADHARAM
金额:
$27.6万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-09-30 至 1996-08-31
关键词:
AIDS therapy Mycobacterium avium antibacterial agents combination chemotherapy drug administration rate /duration drug adverse effect host organism interaction laboratory mouse liposomes microorganism disease chemotherapy monocyte nonhuman therapy evaluation opportunistic infections streptomycin tissue /cell culture
中文摘要
禽分枝杆菌-细胞内复合体(MAC)引起严重的
获得性肺炎患者的播散性细菌感染
免疫缺陷综合征(艾滋病)。艾滋病患者的Mac感染是
对目前可用的抗分枝杆菌药物基本耐药。这些
病原体主要定位于网状内皮细胞的巨噬细胞。
系统(资源)。脂质体是一种磷脂微囊,可以包裹
抗生素,并被RES热衷于使用。基于以前的
研究表明几种脂质体具有较好的疗效
抗褐鼠和培养巨噬细胞中MAC感染的抗生素,
该项目的中心假设是,将抗生素定位于
MAC感染的细胞内部位增加了它们的疗效和
降低它们的毒性。拟议的研究将建立有针对性的
米色小鼠MAC的治疗,这是一种已建立的这种疾病的动物模型。
脂质体的最佳剂量、给药程序和组合--
包裹型抗生素,包括链霉素、阿米卡星和
氯法齐明,将被确定,以实现最大限度的抗分枝杆菌
对感染MAC的褐鼠的影响。阿司匹林的体内治疗作用
脂质体中有希望的新药,包括环丙沙星,
将对司帕沙星和克拉霉素进行调查。的影响
脂质体包裹抗生素对人外周血巨噬细胞生长的影响
将对血液单核细胞进行调查,以确定脂质体
给药增强了这些抗生素和它们的抗MAC活性
联合用药,以及评估其他抗分枝杆菌新药。
英文摘要
Mycobacterium avium-intracellulare complex (MAC) causes serious
disseminated bacterial infection in patients with the acquired
immunodeficiency syndrome (AIDS). MAC infection in AIDS patients is
largely resistant to currently available antimycobacterial drugs. These
pathogens localize primarily in the macrophages of the reticuloendothelial
system (RES). Liposomes are phospholipid vesicles that can encapsulate
antibiotics, and are avidly taken up by the RES. Based on previous
studies indicating the superior efficacy of several liposome-encapsulated
antibiotics against MAC infections in beige mice and cultured macrophages,
the central hypothesis of this projects is that targeting antibiotics to
the intracellular sites of MAC infection increases their efficacy and
reduces their toxicity. The proposed research will establish targeted
therapy of MAC in beige mice, an established animal model of this disease.
The optimal dose, schedule of administration and combination of liposome-
encapsulated antibiotics, including streptomycin, amikacin and
clofazimine, will be determined, to achieve maximal antimycobacterial
effects in MAC-infected beige mice. The in vivo therapeutic effect of
promising new drugs encapsulated in liposomes, including ciprofloxacin,
sparfloxacin and clarithromycin, will be investigated. The effect of
liposome-encapsulated antibiotics on the growth of MAC in human peripheral
blood monocytes will be investigated, to ascertain whether liposomal
delivery enhances the anti-MAC activity of these antibiotics and their
combinations, as well as to evaluate other new antimycobacterial drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GANGADHARAM, PATTISAPU R
-
批准号:2068895
-
项目类别:
-
资助金额:$28.07万
-
财政年份:1993
-
负责人:PATTISAPU R GANGADHARAM
-
依托单位:
TARGETED THERAPY OF MYCOBACTERIUM AVIUM INFECTIONS
-
批准号:2327186
-
项目类别:
-
资助金额:$4.9万
-
财政年份:1993
-
负责人:PATTISAPU R GANGADHARAM
-
依托单位:
GANGADHARAM, PATTISAPU R
-
批准号:2068894
-
项目类别:
-
资助金额:$26.87万
-
财政年份:1993
-
负责人:PATTISAPU R GANGADHARAM
-
依托单位:
IMMUNOPATHOLOGY OF MYCOBACTERIUM INTRACELLULARE IN AIDS
-
批准号:3132381
-
项目类别:
-
资助金额:$12.52万
-
财政年份:1990
-
负责人:PATTISAPU R GANGADHARAM
-
依托单位:
IMMUNOPATHOLOGY OF MYCOBACTERIUM INTRACELLULARE IN AIDS
-
批准号:3132380
-
项目类别:
-
资助金额:$12.39万
-
财政年份:1984
-
负责人:PATTISAPU R GANGADHARAM
-
依托单位:
IMMUNOPATHOLOGY OF MYCOBACTERIUM INTRACELLULARE IN AIDS
-
批准号:3132373
-
项目类别:
-
资助金额:$11.51万
-
财政年份:1984
-
负责人:PATTISAPU R GANGADHARAM
-
依托单位:
IMMUNOPATHOLOGY OF MYCOBACTERIUM INTRACELLULARE IN AIDS
-
批准号:3132377
-
项目类别:
-
资助金额:$11.78万
-
财政年份:1984
-
负责人:PATTISAPU R GANGADHARAM
-
依托单位:
IMMUNOPATHOLOGY OF MYCOBACTERIUM INTRACELLULARE IN AIDS
-
批准号:3132378
-
项目类别:
-
资助金额:$11.35万
-
财政年份:1984
-
负责人:PATTISAPU R GANGADHARAM
-
依托单位:
IMMUNOPATHOLOGY OF MYCOBACTERIUM INTRACELLULARE IN AIDS
-
批准号:3132379
-
项目类别:
-
资助金额:$11.98万
-
财政年份:1984
-
负责人:PATTISAPU R GANGADHARAM
-
依托单位:
海外基金